Literature DB >> 15749195

Atrioventricular conduction disturbances in a young patient with Fabry's disease without other signs of cardiac involvement.

Nikos T Kouris, Dimitra D Kontogianni, Maria T Pavlou, Dimitris K Babalis.   

Abstract

A 30 year-old male patient with a history of Fabry's disease, was referred to hospital with symptoms of dizziness, hypotension and weakness. Fabry's disease had been diagnosed 2 years before, based on angiokeratoma and hypohidrosis on physical examination and complete lack of alpha-galactosidase A on laboratory examination. The ECG on admission demonstrated sinus bradycardia, with a poor response to atropine administration. Echocardiograms on admission and 2 years before were normal, as well as Holter ambulatory ECG recording. Subsequent electrophysiological study demonstrated mild AV conduction disturbances at a site proximal to His, and the patient was simply advised to be regularly followed up. It can therefore be concluded that even young patients with Fabry's disease and normal echocardiograms might develop cardiac symptoms due to AV conduction abnormalities.

Entities:  

Mesh:

Year:  2005        PMID: 15749195     DOI: 10.1016/j.ijcard.2003.10.065

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Severe bradyarrhythmia linked to left atrial dysfunction in Fabry disease-A cross-sectional study.

Authors:  Lu Zhao Di; Maxime Pichette; Réginald Nadeau; Daniel G Bichet; Frédéric Poulin
Journal:  Clin Cardiol       Date:  2018-09-20       Impact factor: 2.882

2.  Progression of electrocardiogram changes in an untreated fabry disease: a case report.

Authors:  Isabel Mattig; Sima Canaan-Kühl; Christoph Tillmanns; Fabian Knebel
Journal:  Eur Heart J Case Rep       Date:  2021-02-20

3.  Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease.

Authors:  Aurelie Nguyen Dinh Cat; Brigitte Escoubet; Vincent Agrapart; Violaine Griol-Charhbili; Trenton Schoeb; Wenguang Feng; Edgar Jaimes; David G Warnock; Frederic Jaisser
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.